East Brunswick, NJNCT06349408Now EnrollingIRB Ready

Locally Advanced Solid Tumor Clinical Trial in East Brunswick, NJ

Access cutting-edge locally advanced solid tumor treatment through this phase 1 clinical trial at a research site in East Brunswick. Study-provided care at no cost to qualified participants.

Sponsored by Fortvita Biologics (USA)Inc.

Quick Self-Assessment

See if you qualify for this East Brunswick location

Preparing your pre-screening questions…

Expert Care in East Brunswick

Access locally advanced solid tumor specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related locally advanced solid tumor treatment provided free

Apply for This East Brunswick Location

Check if you qualify for this locally advanced solid tumor clinical trial in East Brunswick, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Brunswick

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Brunswick site if eligible
  4. 4Begin participation

About This Locally Advanced Solid Tumor Study in East Brunswick

This is a Phase 1 multicenter, multi-regional, open-label, first-in-human study of IBI3001 in participants with unresectable, locally advanced or metastatic solid tumors. The purpose of this study is to identify the MTD/RP2D of IBI3001, and to explore the preliminary efficacy of IBI3001.

Sponsor: Fortvita Biologics (USA)Inc.

Who Can Participate

Inclusion Criteria

Male or female participants ≥ 18 years old;
Has an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1;
Has an anticipated life expectancy of ≥ 12 weeks;
Adequate bone marrow and organ function:
At least 1 evaluable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1. for dose escalation , and 1 measurable lesion for dose expansion.
Has a documented (histologically- or cytologically-proven), unresectable, locally advanced or metastatic solid tumor that is refractory to or intolerable with standard treatment, or for which no standard treatment is available; participants who refuse standard therapy, or are able to suspend standard therapy without major risks. Key

Exclusion Criteria

Progressed or refractory to an ADC that consists of an Exatecan derivative that is a topoisomerase I inhibitor or intolerable with an ADC that consists of Exatecan;
Plan to receive other antitumor therapy during the study excluding palliative radiotherapy for the purpose of symptom (like pain) relief that must also not have an impact on tumor assessment throughout the study;
Pyloric obstruction and/or persistent recurrent vomiting (≥ 3 times in 24 hours);
Gastrointestinal perforation and/or fistula within 6 months prior to first administration of the study drug, and not recovered after surgical treatment;
Known symptomatic central nervous system (CNS) metastases.
History of pneumonia requiring corticosteroids therapy, or history of clinically significant lung diseases; Uncontrolled diseases;
History of endotracheal or gastrointestinal stent implantation;
Ascites, pleural effusion, or pericardial effusion with symptoms and requiring intervention;
Esophageal or gastric varices requiring immediate intervention;
Not eligible to participate in this study at the discretion of the investigator;
Do not have adequate treatment washout period before study drug administration. -

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Brunswick?

Yes, this clinical trial (NCT06349408) has an active research site in East Brunswick, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Locally Advanced Solid Tumor Treatment Options in East Brunswick, NJ

If you're searching for locally advanced solid tumor treatment options in East Brunswick, NJ, this clinical trial (NCT06349408) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Brunswick research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced locally advanced solid tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all locally advanced solid tumor clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in East Brunswick, NJ

See all leukemia clinical trials recruiting in East Brunswick — not just this study.

Browse Leukemia Trials in East Brunswick →

Browse More Trials by Condition

Leukemia TrialsAdvanced Solid Tumors TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in East Brunswick?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Brunswick, NJ